©The Author(s) 2025.
World J Gastroenterol. Nov 14, 2025; 31(42): 112478
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.112478
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.112478
Table 3 Univariate logistic regression analysis and multivariate stepwise regression analysis
| Variables | Univariate analysis | Multivariate analysis | Variables | Univariate analysis |
| OR (95%CI) | P value | OR (95%CI) | P value | |
| Age ≥ 60 years | 2.248 (1.360-3.718) | 0.002 | 1.957 (1.099-3.484) | 0.023 |
| Female sex | 1.320 (0.784-2.220) | 0.296 | ||
| BMI | 0.895 (0.830-0.964) | 0.003 | 0.936 (0.866-1.011) | 0.092 |
| Diabetes | 1.454 (0.877-2.411) | 0.147 | 1.998 (1.089-3.663) | 0.025 |
| Hypertension | 0.983 (0.565-1.711) | 0.953 | ||
| Malignant tumor | 4.522 (2.309-8.857) | < 0.001 | 3.968 (1.810-8.699) | < 0.001 |
| Charlson Comorbidity Index | 1.357 (1.193-1.543) | < 0.001 | ||
| laboratory examination | ||||
| White blood cell count (× 109/L) | 1.001 (0.964-1.040) | 0.961 | ||
| Absolute lymphocyte count (× 109/L) | 0.912 (0.585-1.421) | 0.822 | ||
| Neutrophil count (× 109/L) | 1.003 (0.965-1.043) | 0.866 | ||
| Neutral-lymphocyte ratio | 1.002 (0.985-1.019) | 0.811 | ||
| Hemoglobin (g/L) | 0.970 (0.956-0.983) | < 0.001 | ||
| Platelet count (× 109/L) | 0.999 (0.998-1.001) | 0.509 | ||
| CRP (mg/L) | 0.996 (0.993-0.999) | 0.013 | 0.993 (0.990-0.997) | 0.001 |
| ALT (U/L) | 0.997 (0.994-1.000) | 0.036 | ||
| AST (U/L) | 0.998 (0.996-1.000) | 0.094 | 0.998 (0.995-1.000) | 0.082 |
| GGT (U/L) | 1.001 (1.000-1.003) | 0.088 | 1.002 (1.000-1.004) | 0.081 |
| Albumin (g/L) | 0.954 (0.915-0.996) | 0.030 | 0.955 (0.907-1.004) | 0.073 |
| Total bilirubin | 1.000 (0.992-1.008) | 0.951 | ||
| APTT (seconds) | 1.016 (0.962-1.074) | 0.567 | 1.058 (0.978-1.145) | 0.157 |
| PT (seconds) | 1.026 (0.988-1.066) | 0.180 | 1.065 (1.007-1.127) | 0.028 |
| PCT (ng/mL) | 0.997 (0.988-1.007) | 0.550 | ||
| IL-6 (pg/mL) | 1.000 (1.000-1.000) | 0.674 | ||
| Imaging results | ||||
| Abscess size (mm) | 0.992 (0.984-1.001) | 0.076 | ||
| Abscess location | ||||
| Right lobe | ||||
| Left lobe | 0.685 (0.336-1.399) | 0.300 | ||
| Bilateral | 1.074 (0.414-2.781) | 0.884 | ||
| Multiple abscesses | 1.614 (0.957-2.721) | 0.073 | ||
| Co-existing with other infections | ||||
| Pulmonary infection | 0.700 (0.414-1.185) | 0.185 | 0.562 (0.303-1.044) | 0.068 |
| Comorbidities | ||||
| Septic shock | 1.185 (0.537-2.618) | 0.674 | ||
| Pleural effusion | 1.133 (0.658-1.951) | 0.653 | ||
| Ascites | 1.604 (0.615-4.183) | 0.334 | ||
| Biliary tract diseases | 2.442 (1.455-4.099) | < 0.001 | ||
| Heart failure | 0.691 (0.233-2.048) | 0.505 | ||
| Renal insufficiency | 0.765 (0.254-2.304) | 0.634 |
- Citation: Xu K, Wu DH, Zeng CJ, Guo JY, Xi DY, Wang MJ, Yao ZY, Feng AQ, Ji F, Yan XB, Ye LL, Li CY. Clinical predictors of multidrug-resistant Gram-negative pyogenic liver abscess and nomogram construction: A retrospective analysis. World J Gastroenterol 2025; 31(42): 112478
- URL: https://www.wjgnet.com/1007-9327/full/v31/i42/112478.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i42.112478